1. 1452PCombination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation. (23rd October 2018) Authors: Viteri, S; Chang, G-C; Chiari, R; Cho, B C; Ciardiello, F; Curigliano, G; Hida, T; Lee, D H; Lim, W T D; Lin, C-C; Martinez, A; Murakami, H; Natsume, I; Nishio, M; Paz-Ares, L; Soo, R A; Cattan, V; Gandossi, E; Heck, H; Park, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1455PComparative analysis of overall survival using propensity score between first- and second-generation EGFR-TKI: Real world data of 1354 patients with EGFR mutant NSCLC. (23rd October 2018) Authors: Ito, K; Murotani, K; Kubo, A; Kunii, E; Taniguchi, H; Shindo, J; Asada, K; Imaizumi, K; Tanaka, K; Inui, N; Okuno, M; Hataji, O; Hayai, S; Abe, T; Kimura, T; Tsuda, T; Yamaguchi, T; Oya, Y; Yoshida, T; Hida, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 389PRisk factors of nivolumab-induced pneumonitis in patients with solid tumors. (25th November 2018) Authors: Yamaguchi, T; Hasegawa, T; Hanai, N; Inaba, Y; Muro, K; Hida, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LBA52Results of the GEOMETRY mono-1 phase II study for evaluation of the MET inhibitor capmatinib (INC280) in patients (pts) with METΔex14 mutated advanced non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Wolf, J; Seto, T; Han, J-Y; Reguart, N; Garon, E B; Groen, H J M; Tan, D S; Hida, T; de Jonge, M J A; Orlov, S V; Smit, E F; Souquet, P-J; Vansteenkiste, J F; Giovannini, M; Le Mouhaer, S; Robeva, A; Waldron-Lynch, M; Heist, R S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LBA61Phase II results for single-agent nazartinib (EGF816) in adult patients (pts) with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Tan, D S; Kim, S-W; Sequist, L V; Ponce Aix, S; Smit, E F; Hida, T; Yang, J C-H; Felip, E; Seto, T; Grohe, C; Wolf, J; Ko, J; Marriere, E; Belli, R; Giovannini, M; Kim, D-W Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Primary band-shaped spheroidal degeneration of the cornea: three cases from two consanguineous families. Issue 5 (May 1986) Authors: Hida, T; Kigasawa, K; Tanaka, E; Akiya, S; Tashiro, Y; Hosoda, Y Journal: British journal of ophthalmology Issue: Volume 70:Issue 5(1986) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Trans-Tenon's retrobulbar triamcinolone infusion for small choroidal neovascularisation. Issue 8 (16th July 2004) Authors: Okada, A A; Wakabayashi, T; Kojima, E; Asano, Y; Hida, T Journal: British journal of ophthalmology Issue: Volume 88:Issue 8(2004) Page Start: 1097 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Issue 8 (24th July 2003) Authors: Okada, A A; Wakabayashi, T; Morimura, Y; Kawahara, S; Kojima, E; Asano, Y; Hida, T Journal: British journal of ophthalmology Issue: Volume 87:Issue 8(2003) Page Start: 968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗